AVGO vs. ADMA
AVGO (Broadcom Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. AVGO operates in Semiconductors (Technology), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, AVGO returned 41.32%/yr vs 1.08%/yr for ADMA. At a 0.18 correlation, their price movements are largely independent.
Performance
AVGO vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVGO achieves a 14.83% return, which is significantly higher than ADMA's -55.81% return. Over the past 10 years, AVGO has outperformed ADMA with an annualized return of 41.32%, while ADMA has yielded a comparatively lower 1.08% annualized return.
AVGO
- 1D
- 2.82%
- 1M
- -7.77%
- YTD
- 14.83%
- 6M
- -0.72%
- 1Y
- 61.91%
- 3Y*
- 72.46%
- 5Y*
- 56.70%
- 10Y*
- 41.32%
ADMA
- 1D
- 1.13%
- 1M
- -1.35%
- YTD
- -55.81%
- 6M
- -58.43%
- 1Y
- -60.89%
- 3Y*
- 28.26%
- 5Y*
- 34.37%
- 10Y*
- 1.08%
AVGO vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 14.83% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
ADMA ADMA Biologics, Inc. | -55.81% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between AVGO and ADMA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.18 |
The correlation between AVGO and ADMA shifts across timeframes, from 0.13 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AVGO:
$1.93T
ADMA:
$1.93B
AVGO:
$6.01
ADMA:
$0.68
AVGO:
65.99
ADMA:
11.91
AVGO:
25.64
ADMA:
3.86
AVGO:
22.05
ADMA:
4.95
AVGO:
$75.47B
ADMA:
$509.86M
AVGO:
$50.53B
ADMA:
$312.42M
AVGO:
$41.76B
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVGO vs. ADMA — Risk / Return Rank
AVGO
ADMA
AVGO vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Broadcom Inc. (AVGO) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AVGO | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.49 | ||
| Sortino ratioReturn per unit of downside risk | +3.71 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 0.77 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 2.17 | -0.94 | +3.11 |
| Martin ratioReturn relative to average drawdown | 5.16 | -1.81 | +6.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AVGO | ADMA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.38 | -1.12 | +2.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.32 | 0.58 | +0.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.05 | 0.02 | +1.04 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.09 | -0.01 | +1.10 |
Drawdowns
AVGO vs. ADMA - Drawdown Comparison
The maximum AVGO drawdown since its inception was -48.30%, smaller than the maximum ADMA drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for AVGO and ADMA.
Loading charts...
Drawdown Indicators
| AVGO | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.30% | -91.28% | +42.98% |
Max Drawdown (1Y)Largest decline over 1 year | -28.67% | -65.25% | +36.58% |
Max Drawdown (3Y)Largest decline over 3 years | -41.15% | -68.99% | +27.84% |
Max Drawdown (5Y)Largest decline over 5 years | -41.15% | -68.99% | +27.84% |
Max Drawdown (10Y)Largest decline over 10 years | -48.30% | -86.11% | +37.81% |
Current DrawdownCurrent decline from peak | -17.64% | -67.12% | +49.48% |
Average DrawdownAverage peak-to-trough decline | -7.97% | -53.05% | +45.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.03% | 33.62% | -21.59% |
Volatility
AVGO vs. ADMA - Volatility Comparison
Broadcom Inc. (AVGO) has a higher volatility of 20.09% compared to ADMA Biologics, Inc. (ADMA) at 11.89%. This indicates that AVGO's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVGO | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.09% | 11.89% | +8.20% |
Volatility (6M)Calculated over the trailing 6-month period | 34.69% | 45.36% | -10.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.31% | 54.73% | -9.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.31% | 59.46% | -16.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.48% | 69.05% | -29.57% |
Dividends
AVGO vs. ADMA - Dividend Comparison
AVGO's dividend yield for the trailing twelve months is around 0.63%, while ADMA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 0.63% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
Financials
AVGO vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between Broadcom Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVGO vs. ADMA - Profitability Comparison
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
AVGO and ADMA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (20.09%) compared to ADMA (11.89%). In terms of maximum drawdown, AVGO dropped -48.30% vs ADMA's -91.28%.
AVGO currently has the higher Sharpe Ratio (1.38 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVGO and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer